ENVALITH
小野薬品工業株式会社 logo

ONO PHARMACEUTICAL CO., LTD.

4528Prime MarketPharmaceuticals

小野薬品工業株式会社 logo
ONO PHARMACEUTICAL CO., LTD.4528
Reference Indicators

Market Cap

11,954¥100M

P/E (Forecast)

15.9x

P/B

1.3x

Dividend Yield (Forecast)

3.34%

ROE

8.2%

EV/EBITDA

7.4x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
361,361447,187502,672486,871515,785
Cost of Sales
93,511110,062127,126147,950141,716
Gross Profit
267,850337,124375,547338,921374,069
SG&A Expenses
77,05789,486100,270125,671123,691
Operating Income
103,195141,963159,93559,74792,236
Pre-tax Income
105,025143,532163,73459,32892,654
Income Taxes
24,34030,61935,6949,16322,743
Net Income
80,519112,723127,97750,04769,767
EBITDA
120,916159,414178,07586,641129,988
Gross Margin
74.1%75.4%74.7%69.6%72.5%
Operating Margin
28.6%31.7%31.8%12.3%17.9%
ROA
10.9%12.8%14.0%4.7%6.3%
ROE
12.3%15.2%16.1%6.4%8.2%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
医薬品事業000.0%